查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1791631

全球DNA與基因克隆服務市場

DNA and Gene Cloning Services
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 178 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球 DNA 和基因克隆服務市場規模將達到 78 億美元

全球DNA和基因克隆服務市場規模預計在2024年為31億美元，預計到2030年將達到78億美元，2024年至2030年的複合年成長率為16.5%。基因合成服務是本報告分析的細分市場之一，預計其複合年成長率將達到18.0%，到分析期結束時將達到37億美元。客製化克隆服務細分市場在分析期間內的複合年成長率預計為13.5%。

美國市場規模估計為 8.222 億美元，中國市場預計複合年成長率為 15.4%

美國DNA和基因克隆服務市場規模預計在2024年達到8.222億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到12億美元，在2024-2030年的分析期間內，複合年成長率為15.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為15.4%和14.1%。在歐洲，預計德國市場的複合年成長率為11.9%。

全球 DNA 和基因克隆服務市場 - 主要趨勢和促進因素摘要

合成生物學作用的不斷擴大是否會增加克隆服務的需求？

合成生物學正迅速崛起，成為一個變革性領域，推動著生物技術、醫療保健和工業領域的空前創新。這項變革的核心是 DNA 和基因克隆服務，它們是操縱遺傳物質以設計新生物系統和產品的重要工具。客製化基因合成、載體建構和質體克隆的需求日益成長，這與合成生物學在下一代療法、疫苗、診斷方法和生物基材料開發中的應用日益廣泛密切相關。在藥物研發領域，基因克隆被廣泛用於表達治療性蛋白質、研究基因功能和建立疾病模型。此外，包括 COVID-19 大流行在內的近期全球健康趨勢凸顯了快速基因工程對於疫苗開發的重要性，使 DNA 和基因克隆成為人們關注的焦點。克隆服務使研究人員能夠高精度地複製特定的 DNA 序列，對於大規模生產重組蛋白和單株抗體至關重要。隨著學術機構、生技公司和委外研發機構(CRO) 之間的合作日益增多，將克隆服務外包給擁有先進分子生物學能力的專業供應商的趨勢日益明顯。這些供應商提供從基因設計到檢驗的一體化解決方案，簡化了研究流程並降低了技術門檻。此外，克隆試劑套件、自動化工具和線上設計平台的出現，拓寬了非專業實驗室的使用管道，使基因編輯技術的使用更加民主化。 CRISPR-Cas 系統和基因組工程的創新步伐日益加快，進一步加速了對高保真克隆服務的需求，以支持基因敲入、敲除和誘變研究，這使得 DNA 和基因克隆成為未來生物技術的核心。

技術進步是否使克隆過程更有效率和準確？

分子生物學和基因組學的技術進步顯著提高了 DNA 和基因克隆服務的效率、準確性和擴充性。傳統的涉及限制性內切酶和連接酶的方法已發展成為更特異性的技術，例如 Gibson 組裝、Golden Gate 克隆和定點突變，從而可以實現更快、更無縫的 DNA 組裝。這些技術可以將基因序列精確地插入載體，減少克隆錯誤並能夠建立複雜的遺傳迴路。自動化是另一項重大變革。高通量機器人系統現在能夠以驚人的速度和可重複性執行重複性克隆任務，使服務提供者能夠在短的周轉時間內提供大量客製化的 DNA 構建體。結合即時PCR和次世代定序(NGS)檢驗，這些系統可確保整個克隆工作流程的高品質控制。人工智慧也在擴大其作用，特別是在最佳化基因序列以在各種宿主生物（如大腸桿菌、酵母和哺乳動物細胞）中表達方面。 AI 演算法分析密碼子使用、mRNA 結構和 GC 含量，以提高翻譯效率和蛋白質產量。此外，載體設計方面的創新，例如可誘導、多克隆和組織特異性表達系統的開發，擴展了基因克隆在治療、農業和工業領域應用的多功能性。雲端基礎的計劃管理和 LIMS 平台實現了客戶和服務供應商之間的無縫溝通，提高了透明度、可追溯性和資料共用。這些技術飛躍不僅改善了研究成果，而且還幫助研究機構滿足嚴格的監管和品質標準，特別是對於克隆基因的臨床和商業級應用。隨著對精準生物技術的需求不斷成長，這些尖端工具的整合繼續為 DNA 和基因克隆服務設定新的性能基準。

轉向外包和客製化的轉變會重新定義服務交付模式嗎？

隨著生物技術和製藥研究日益複雜且數據驅動，各組織正將外包視為縮短開發週期和獲得專業知識的策略性舉措。 DNA和基因克隆服務處於這一外包趨勢的前沿，企業更傾向於選擇外部合作夥伴來完成基因合成、載體工程、表達檢驗和文庫建構等任務。外包模式具有明顯的優勢，包括快速的計劃週轉、專業的基礎設施存取和成本效益。領先的服務供應商現在提供高度可自訂的解決方案，讓客戶可以根據長度、序列、標籤、表達系統甚至密碼子最佳化偏好來指定基因構建體。這種程度的客製化得益於先進的生物資訊平台，這些平台可在合成開始前協助進行基因設計、錯誤檢查和最佳化。此外，下游應用和服務（例如蛋白質表現、純化和功能分析）通常會捆綁在一起，從而從單一來源提供端到端的分子生物學解決方案。由於克隆的基因序列通常是對創新流程至關重要的專有訊息，因此智慧財產權保護和保密性也變得越來越重要。為了應對這項挑戰，企業正在實施嚴格的資料安全通訊協定，例如基於區塊鏈的樣本追蹤和序列加密傳輸。越來越多的服務供應商，尤其是在包括中國和印度在內的亞太地區，正在提供既經濟高效又不影響品質的選擇，進一步促進競爭和創新。學術機構也擴大與商業供應商合作，以便為大型合作計劃提供大規模克隆服務。這種服務交付方式的轉變不僅最佳化了研究效率，也使DNA和基因克隆成為更廣泛的生命科學生態系統中重要的外包服務。

推動 DNA 和基因克隆服務市場發展的關鍵成長要素有哪些？

DNA 和基因克隆服務市場的成長受到與技術進步、研究多樣化以及生物技術和生命科學領域消費行為變化直接相關的多種因素的驅動。一個關鍵促進因素是合成生物學、免疫療法、疫苗開發和農業生物技術等領域基因研究範圍的不斷擴大，這些領域都嚴重依賴基因克隆來創建用於實驗和治療用途的功能性構建體。 CRISPR-Cas9 和 TALEN 等基因編輯技術的廣泛應用進一步推動了對精準克隆服務的需求，以支持基因改造，無論是用於疾病建模還是功能性基因篩檢。同時，生物製藥管線中單株抗體、細胞療法和重組蛋白的興起，對透過克隆建構的可靠表現系統產生了持續的需求。另一個關鍵促進因素是生命科學的分散化趨勢。中小型企業 (SME)、學術衍生企業和獨立實驗室正在承擔更雄心勃勃的計劃，但通常缺乏完成複雜克隆任務的內部能力，因此轉向專業服務供應商。全球個別化醫療和標靶治療的發展也刺激了針對個別患者特徵和特定適應症客製化基因構建體的需求。此外，用於篩檢藥物標靶、酵素和結合域的合成基因庫的開發，正在將克隆服務的效用擴展到傳統研究應用之外。自動化高通量系統、人工智慧主導的序列設計和先進的載體系統等技術推動因素正在提高擴充性和可靠性，使提供者能夠為具有複雜需求的更多不同類型的客戶提供服務。最後，國際合作、研究津貼和政府支持的基因組計畫正在為分子生物學基礎設施注入大量資金，為持續的市場擴張創造了肥沃的土壤。這些共同的力量不僅拓寬了市場基礎，而且還牢固地確立了 DNA 和基因克隆服務作為現代生物科學創新基本組成部分的地位。

部分

服務（基因合成服務、客製化克隆服務、亞克隆服務、其他服務）、應用（DNA定序、誘變、基因分型、其他應用）、最終用途（學術和研究機構、製藥和生物技術公司、CMO和CRO）

受訪公司範例

  • abm Inc.（Applied Biological Materials）
  • ATUM
  • Bio Basic Inc.
  • BioCat GmbH
  • Biolegio BV
  • BioS&T
  • Blue Heron Biotech
  • Creative Biogene
  • Dundee Cell Products
  • Eurofins Genomics
  • Eurogentec
  • GenScript
  • GENEWIZ from Azenta Life Sciences
  • Genovac
  • GenScript Biotech Corporation
  • Integrated DNA Technologies（IDT）
  • Invitrogen（Thermo Fisher Scientific）
  • Macrogen
  • OriGene Technologies
  • ProteoGenix

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP30555

Global DNA and Gene Cloning Services Market to Reach US$7.8 Billion by 2030

The global market for DNA and Gene Cloning Services estimated at US$3.1 Billion in the year 2024, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2024-2030. Gene Synthesis Service, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Custom Cloning Service segment is estimated at 13.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$822.2 Million While China is Forecast to Grow at 15.4% CAGR

The DNA and Gene Cloning Services market in the U.S. is estimated at US$822.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 15.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.4% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.9% CAGR.

Global DNA and Gene Cloning Services Market - Key Trends & Drivers Summarized

Is the Expanding Role of Synthetic Biology Elevating the Demand for Cloning Services?

Synthetic biology has rapidly emerged as a transformative field, driving unprecedented innovation across biotechnology, healthcare, and industrial sectors. At the heart of this movement lies DNA and gene cloning services, which have become essential tools for manipulating genetic material to design novel biological systems and products. The rising demand for custom gene synthesis, vector construction, and plasmid cloning is closely tied to the growing applications of synthetic biology in developing next-generation therapeutics, vaccines, diagnostics, and bio-based materials. In pharmaceutical R&D, gene cloning is used extensively to express therapeutic proteins, study gene function, and engineer disease models. Moreover, in the wake of recent global health challenges, including the COVID-19 pandemic, the importance of rapid genetic engineering for vaccine development has pushed DNA and gene cloning into the spotlight. Cloning services enable researchers to replicate specific DNA sequences with high precision, which is vital for producing recombinant proteins and monoclonal antibodies at scale. The growing collaboration between academic institutions, biotech firms, and contract research organizations (CROs) has led to a steady outsourcing trend, where cloning services are provided by specialized vendors with advanced molecular biology capabilities. These vendors offer integrated solutions-from gene design to expression validation-streamlining research timelines and reducing technical barriers. Additionally, the availability of cloning kits, automation tools, and online design platforms is expanding access to non-specialist labs, democratizing the use of gene editing technologies. The increasing pace of innovation in CRISPR-Cas systems and genome engineering is further accelerating demand for high-fidelity cloning services that support gene knock-ins, knockouts, and mutagenesis studies, making DNA and gene cloning central to the future of bioengineering.

Are Technological Advancements Enhancing the Efficiency and Precision of Cloning Processes?

Technological advancements in molecular biology and genomics are significantly enhancing the efficiency, accuracy, and scalability of DNA and gene cloning services. Traditional methods involving restriction enzymes and ligases have evolved into more sophisticated techniques such as Gibson Assembly, Golden Gate cloning, and site-directed mutagenesis, enabling faster and more seamless DNA assembly. These techniques allow for the precise insertion of genetic sequences into vectors, reducing cloning errors and enabling the construction of complex genetic circuits. Automation is another major game-changer-high-throughput robotic systems now perform repetitive cloning tasks with remarkable speed and reproducibility, allowing service providers to deliver large volumes of customized DNA constructs within short turnaround times. Coupled with real-time PCR and next-generation sequencing (NGS) validation, these systems ensure high-quality control across the cloning workflow. Artificial intelligence is also playing a growing role, particularly in gene sequence optimization for expression in various host organisms, such as E. coli, yeast, or mammalian cells. AI algorithms analyze codon usage, mRNA structure, and GC content to improve translation efficiency and protein yield. Furthermore, innovations in vector design-such as the development of inducible, multi-cloning, and tissue-specific expression systems-have expanded the versatility of gene cloning applications across therapeutic, agricultural, and industrial domains. Cloud-based project management and LIMS platforms now allow seamless communication between clients and service providers, improving transparency, traceability, and data sharing. These technological leaps are not only improving research output but also helping institutions meet rigorous regulatory and quality standards, particularly in clinical and commercial-grade applications of cloned genes. As the demand for precision biotechnology rises, the integration of these cutting-edge tools continues to set new performance benchmarks for DNA and gene cloning services.

Is the Shift Toward Outsourcing and Customization Redefining Service Delivery Models?

As biotechnology and pharmaceutical research becomes increasingly complex and data-driven, organizations are turning to outsourcing as a strategic move to accelerate development timelines and access specialized expertise. DNA and gene cloning services are at the forefront of this outsourcing trend, with companies preferring external partners for tasks such as gene synthesis, vector engineering, expression validation, and library construction. The outsourcing model offers clear advantages: faster project turnaround, access to specialized infrastructure, and cost efficiency-especially for smaller labs and startups with limited in-house capabilities. Leading service providers now offer highly customizable solutions, where clients can specify gene constructs based on length, sequence, tags, expression systems, and even codon optimization preferences. This level of customization is supported by advanced bioinformatics platforms that assist in gene design, error checking, and optimization before synthesis begins. Additionally, services are often bundled with downstream applications such as protein expression, purification, and functional assays, providing end-to-end molecular biology solutions under one roof. There is also a growing emphasis on IP protection and confidentiality, as cloned genetic sequences often represent proprietary information critical to innovation pipelines. Companies are responding by implementing stringent data security protocols, including blockchain-based sample tracking and encrypted sequence delivery. Global expansion of service providers, particularly in Asia-Pacific regions like China and India, is driving cost-effective options without compromising quality, further intensifying competition and innovation. Academic institutions, too, are increasingly partnering with commercial providers to access cloning services at scale for large collaborative projects. This shift in service delivery is not only optimizing research productivity but is also establishing DNA and gene cloning as a critical outsourced utility in the broader life sciences ecosystem.

What Are the Main Growth Accelerators Fueling the DNA and Gene Cloning Services Market?

The growth in the DNA and gene cloning services market is driven by several factors directly linked to technological progression, research diversification, and shifting consumer behavior in biotech and life sciences. One of the primary accelerators is the expanding scope of genetic research in fields such as synthetic biology, immunotherapy, vaccine development, and agricultural biotech, all of which rely heavily on gene cloning to create functional constructs for experimental and therapeutic use. The widespread adoption of gene editing technologies like CRISPR-Cas9 and TALEN has further increased the need for precise cloning services to support genetic modifications, whether for disease modeling or functional gene screening. In parallel, the rise of monoclonal antibodies, cell-based therapies, and recombinant proteins in biopharmaceutical pipelines is generating sustained demand for reliable expression systems constructed through cloning. Another significant factor is the trend toward decentralization in life sciences, where small and mid-sized enterprises (SMEs), academic spin-offs, and independent research labs are taking on more ambitious projects, yet often lack the in-house capabilities for complex cloning tasks-thus turning to specialized service providers. The global movement toward personalized medicine and targeted therapies is also fueling demand for custom gene constructs tailored to individual patient profiles or niche indications. Moreover, the development of synthetic gene libraries for screening drug targets, enzymes, or binding domains is expanding the utility of cloning services beyond traditional research applications. Technological enablers such as automated high-throughput systems, AI-driven sequence design, and advanced vector systems are improving scalability and reliability, allowing providers to serve a more diverse clientele with complex requirements. Finally, international collaborations, research grants, and government-backed genomic initiatives are injecting substantial funding into molecular biology infrastructure, creating fertile ground for sustained market expansion. These collective forces are not only broadening the market base but are solidifying DNA and gene cloning services as a fundamental component of modern bioscience innovation.

SCOPE OF STUDY:

The report analyzes the DNA and Gene Cloning Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service, Other Services); Application (DNA Sequencing Application, Mutagenesis Application, Genotyping Application, Other Applications); End-Use (Academic & Research Institutes End-Use, Pharma & Biotech Companies End-Use, CMOs & CROs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • abm Inc. (Applied Biological Materials)
  • ATUM
  • Bio Basic Inc.
  • BioCat GmbH
  • Biolegio B.V.
  • BioS&T
  • Blue Heron Biotech
  • Creative Biogene
  • Dundee Cell Products
  • Eurofins Genomics
  • Eurogentec
  • GenScript
  • GENEWIZ from Azenta Life Sciences
  • Genovac
  • GenScript Biotech Corporation
  • Integrated DNA Technologies (IDT)
  • Invitrogen (Thermo Fisher Scientific)
  • Macrogen
  • OriGene Technologies
  • ProteoGenix

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • DNA and Gene Cloning Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Boom in Synthetic Biology Research Throws the Spotlight on Scalable DNA and Gene Cloning Solutions
    • Expanding Use of Gene Cloning in Drug Discovery and Development Propels Growth in Service Demand
    • Rise of Personalized and Targeted Therapies Strengthens Business Case for Customized Gene Constructs
    • Proliferation of CRISPR and Genome Editing Applications Drives Adoption of High-Precision Cloning Services
    • Increasing Outsourcing by Biopharma and Academic Institutions Expands Addressable Market for Specialized Providers
    • Integration of AI and Bioinformatics in Gene Design Accelerates Demand for Intelligent Cloning Platforms
    • Growth of Monoclonal Antibody and Recombinant Protein Production Spurs Demand for Expression-Ready Clones
    • Emergence of High-Throughput and Automated Cloning Workflows Enhances Operational Efficiency and Scalability
    • Adoption of Cloud-Based Platforms for Sequence Management Drives Digital Transformation in Cloning Services
    • Surge in Synthetic Gene Library Construction Generates Opportunities in Functional Genomics and Screening
    • Rising Interest in Rare Disease Research and Orphan Drug Development Spurs Need for Specialized Cloning Capabilities
    • Expansion of Agri-Biotech and Industrial Biotech Pipelines Propels Demand Beyond Traditional Life Sciences Sectors
    • Emphasis on Data Security, IP Protection, and Confidentiality Enhances Trust in Third-Party Gene Cloning Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA and Gene Cloning Services Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for DNA and Gene Cloning Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Gene Synthesis Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Gene Synthesis Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Custom Cloning Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Custom Cloning Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sub-cloning Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Sub-cloning Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for CMOs & CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for CMOs & CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for DNA Sequencing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for DNA Sequencing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Mutagenesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Mutagenesis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Genotyping Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Genotyping Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for DNA and Gene Cloning Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • FRANCE
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • DNA and Gene Cloning Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Service - Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for DNA and Gene Cloning Services by Service - Percentage Breakdown of Value Sales for Gene Synthesis Service, Custom Cloning Service, Sub-cloning Service and Other Services for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by End-Use - Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for DNA and Gene Cloning Services by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, CMOs & CROs End-Use and Academic & Research Institutes End-Use for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for DNA and Gene Cloning Services by Application - DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for DNA and Gene Cloning Services by Application - Percentage Breakdown of Value Sales for DNA Sequencing Application, Mutagenesis Application, Genotyping Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION